FARALLON CAPITAL MANAGEMENT LLC 13F Filings

Review quarterly 13F filings for FARALLON CAPITAL MANAGEMENT LLC.

Quarterly Filings

Reporting periodFiled
2026-06-302026-08-14
2026-03-312026-05-15
2025-12-312026-02-17
2025-09-302025-11-14
2025-06-302025-08-14
2025-03-312025-05-15
2024-12-312025-02-14
2024-09-302024-11-14
2024-06-302024-08-14
2024-03-312024-05-15
2023-12-312024-02-14
2023-09-302023-11-14
2023-06-302023-08-14
2023-03-312023-05-15
2022-12-312023-02-14
2022-09-302022-11-14
2022-06-302022-08-15
2022-03-312022-05-16
2021-12-312022-02-14
2021-09-302021-11-15

Latest Reported Holdings

CompanyTickerReported value
STATE STR SPDR S&P 500 ETF TSPY4480620000
REVOLUTION MEDICINES INCRVMD2537793075
ELECTRONIC ARTS INCEA1623814280
BRIDGEBIO PHARMA INCBBIO800143332
PROTAGONIST THERAPEUTICS INCPTGX778248897
EXELIXIS INCEX9732794424
LIQUIDIA CORPORATIONLQDA666944480
AMAZON COM INCAMZN627547790
LANTHEUS HLDGS INCLNTH619431160
NATERA INCNTRA602175451
UNITEDHEALTH GROUP INCUNH528071215
THERMO FISHER SCIENTIFIC INCTMO526019392
ROIVANT SCIENCES LTD—506395510
AON PLC—458581990
BOSTON SCIENTIFIC CORPBSX449044133
BROADCOM INCAVGO435092450
MICROSOFT CORPMSFT415120156
TANGO THERAPEUTICS INCTNGX383779020
KKR & CO INCKKR377977574
SYNOPSYS INCSNPS370059672

Browse all 13F funds